Pfizer agrees to update Chantix warnings

Two months after the FDA issued a safety alert on Pfizer's Chantix, the company in January agreed to update labeling to warn patients about the potential for serious neuropsychiatric symptoms.

You must be a registered member of MMM to post a comment.

Next Article in Legal/Regulatory